Cyclin-dependent kinase (cdk6) and p16 in pancreatic endocrine neoplasms

Pathology

Volumn 36, Issue 6, 2004, Pages 566-570

  Tomita, Tatsuo ^a,b,c  

^a Texas Tech Medical Center   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cyclin dependent kinases; Cyclins; p16; Pancreatic endocrine neoplasms

Indexed keywords

CYCLIN DEPENDENT KINASE 6; PANCREAS POLYPEPTIDE; PROTEIN P16; PROTEIN P27;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CELL NUCLEUS; CYTOPLASM; ENDOCRINE TUMOR; FEMALE; GASTRINOMA; GLUCAGONOMA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INSULINOMA; MALE; PANCREAS CANCER; PANCREAS ISLET; PANCREATIC POLYPEPTIDOMA; UNITED STATES;

EID: 11844262698     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020400011342     Document Type: Article

References (31)

1. Rosenthal ET, Hurst T, Ruderman JV. Selective translation of mRNA controls: The comparison of protein synthesis during early development of the surf clam. Cell 1980; 20: 489-94.
2. Johnson DG, Walker CL. Cyclins and cell cycle check-points. Annu Rev Pharmacol Toxicol 1999; 39: 295-312.
3. Tsihlias JJ, Kapusta L, Slingerland J. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. Annu Rev Med 1999; 50: 401-32.
4. Tsihlias J, Kapusta LR, DeBooer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N. Loss of cyclin-dependent kinase inhibitor p27 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res 1998; 58: 542-8.
5. Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672-7.
6. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79: 551-5.
7. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase cdk4. Genes Dev 1993; 7: 331-42.
8. Tomita T. New markers for pancreatic islets and islet cell tumors. Pathol Int 2002; 52: 425-32.
9. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of Ki-67 antigen detect proliferating cells in microwave-processed formalin-fixed, paraffin sections. J Pathol 1992; 168: 357-63.
10. Tomita T, Iwata K. Gelatinases and inhibitors of gelatinases in pancreatic islets and islet cell tumors. Mod Pathol 1997; 10: 47-54.
11. Tomita T. Metallothionein in pancreatic endocrine neoplasms. Mod Pathol 2000; 13: 389-95.
12. Tomita T. Immunocytotochemical localization of prohormone convertase 1/3 and 2 in pancreatic islets and islet cell tumors. Pancreas 2001; 23: 172-6.
13. Tomita T. Amylin in human pancreatic islets. Pathology 2003; 35: 34-6.
14. Hoog A, Hu W, Abdel-Halim SM, Falkmer S. Ultrastructural localization of insulin-like growth factor-2 to the secretary granules of insulin cells. Ultrastruct Pathol 1997; 21: 457-66.
15. Alcorta DA, Xiong Y, Phelps D, Hannon C, Bearch D, Barrett C. Involvement of the cyclin-dependent kinase inhibitor p16 in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA 1996; 93: 13742-7.
16. Reithdorf L, Reithdorf S, Lee KR, Cviko A, Loning T, Crum CP. Human papillomavirus expression of p16 and early endocervical glandular neoplasm. Hum Pathol 2002; 33: 899-904.
17. Baba Y, Tsukuda M, Mochimatsu I, Fukukawa S, Kagata H, Satake S. Reduced expression of p16 and p27 proteins in nasopharygeal carcinoma. Cancer Detect Prev 2001; 25: 414-9.
18. Kouvaraki M, Gorgoulis VS, Rassidakis GZ. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas. Cancer 2002; 94: 2454-65.
19. Vis AN, Noordzij MA, Fitoz K, Wildhagen MF, Schroder FH, van der Kwast TH. Prognostic value of cell cycle proteins p27kip1 and MIB-1, and the cell adhesion protein CD 44s in surgically treated patients with prostate cancer. J Urol 2000; 164: 2156-61.
20. Shibata H, Matubara O, Wakiyama H, Tanaka S. The role of cyclin-dependent kinase inhibitor p27 in squamous cell carcinoma of the esophagus. Pathol Res Pract 2001; 197: 157-64.
21. Thomas GU, Szugetu K, Murphy M, Dracetta G, Pagano M, Loda M. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastasis. Am J Pathol 1998; 153: 681-7.
22. Hashimoto K, Nio Y, Sumi S, et al. Correlation between TGF-a beta 1 and p21(WAF1/CIP1) expression and prognosis in respectable invasive ductal carcinoma of the pancreas. Pancreas 2001; 22: 341-7.
23. Tanmapfel A, Grund D, Katalinic A, et al. Decreased expression of p27 protein is associated with advanced tumor stage in hepatocelluar carcinoma. InI J Cancer 2000; 89: 350-5.
24. Huang LW, Chao SL, Hwang JL, Chou YY. Down-regulation of p27 is associated with malignant transformation and aggressive phenotype of cervical neoplasms. Gynecol Oncol 2002; 85: 524-8.
25. Watanabe J, Sato H, Kanai T, et al. Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus-Correlation with proliferation and clinicopathological parameters. Br J Cancer 2002; 87: 81-5.
26. Shigemasa K, Shiroyama Y, Sawasaki T, et al. Underexpression of cyclin-dependent kinase inhibitor p27 is associated with poor prognosis in serous ovarian carcinomas. Int J Oncol 2001; 18: 953-8.
27. Erickson LA, Yousef OM, Jin L, Lohse CM, Pankratz VS, Lloyd RV. p27kip1 expression distinguishes papillary hyperplasia in Grave's disease from papillary thyroid carcinoma. Mod Pathol 2000; 13: 1014-9.
28. Nakabayashi H, Sunada H, Hara M. Immmunohistochemical analysis of cell cycle-regulated protein, apoptosis and proliferation in pituitary adenomas. J Histochem Cytochem 2001; 49: 1193-4.
29. Ali IU, Schweitzer JB, Ikejiri B, Saxena A, Robertson JT, Oldfield EH. Heterogeneity of subcellular localization of p53 pattern in human glioblastomas. Cancer Res 1994; 54: 1-5.
30. Lilja L, Yang SN, Webb DL, Juntti-Berggren I, Bergren PO, Bark C. Cyclin-dependent kinase 5 promotes insulin exocytosis. J Biol Chem 2001; 276: 34199-205.
31. Marzo N, Mora C, Fabregat ME, et al. Pancreatic islets from cyclin-dependent kinase 4/R24C (cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes. Diabetologia 2004; 47: 686-94.